Related Experiment Video
Updated: Oct 13, 2025

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Gut Microbiome in Chronic Coronary Syndrome Patients
Emilia Sawicka-Smiarowska1,2, Kinga Bondarczuk3, Witold Bauer4
1Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Insights
Coronary artery disease (CAD) is linked to significant changes in gut microbiome composition and function. This study found a higher Firmicutes/Bacteroidetes ratio and altered biodiversity in CAD patients, suggesting a role for the gut microbiome in disease development.
Area of Science:
- Microbiology
- Cardiology
- Genomics
Background:
- Classical coronary artery disease (CAD) risk factors do not fully explain high morbidity and mortality rates.
- Emerging research suggests the gut microbiome may play a role in CAD development.
Purpose of the Study:
- To investigate and compare the gut microbiome composition between patients with CAD and a healthy control group.
- To identify specific microbial and functional differences associated with CAD.
Main Methods:
- 16S rRNA gene sequencing (V3-V4 region) was used for microbiome analysis in 169 CAD patients and 166 controls.
- Health assessments and targeted metabolomics were performed.
- Bioinformatic analysis included taxonomic unit identification, biodiversity assessment, and functional prediction.
Main Results:
- Significant differences in 1070 out of 4074 identified taxonomic units were found between groups.
- CAD patients exhibited a higher Firmicutes/Bacteroidetes ratio and altered alpha- and beta-biodiversity.
- Specific microbial pathways and proteins were predicted to be differentially expressed in CAD patients.
Conclusions:
- Coronary artery disease is associated with distinct alterations in gut microbiome composition and function.
- The Firmicutes/Bacteroidetes ratio and microbiome biodiversity are potential biomarkers for CAD.
- Gut microbiome modulation may offer novel therapeutic strategies for CAD.
Abstract:
Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. Therefore, new factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated. This study aimed to evaluate gut microbiome composition in CAD patients in relation to the control group. We examined 169 CAD patients and 166 people in the control group, without CAD, matched in terms of age and sex to the study group. Both populations underwent a detailed health assessment. The microbiome analysis was based on the V3-V4 region of the 16S rRNA gene (NGS method). Among 4074 identified taxonomic units in the whole population, 1070 differed between study groups. The most common bacterial types were Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. Furthermore, a higher Firmicutes/Bacteroidetes ratio in the CAD group compared with the control was demonstrated. Firmicutes/Bacteroidetes ratio, independent of age, sex, CAD status, LDL cholesterol concentration, and statins treatment, was related to altered phosphatidylcholine concentrations obtained in targeted metabolomics. Altered alpha-biodiversity (Kruskal-Wallis test, p = 0.001) and beta-biodiversity (Bray-Curtis metric, p < 0.001) in the CAD group were observed. Moreover, a predicted functional analysis revealed some taxonomic units, metabolic pathways, and proteins that might be characteristic of the CAD patients' microbiome, such as increased expressions of 6-phospho-β-glucosidase and protein-N(pi)-phosphohistidine-sugar phosphotransferase and decreased expressions of DNA topoisomerase, oxaloacetate decarboxylase, and 6-beta-glucosidase. In summary, CAD is associated with altered gut microbiome composition and function.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease II: Pathophysiology

